2025 VCS Heart and Vascular Summit in Richmond

Cardiologists will review common questions on the subjects of Prevention and Detection of Coronary Artery Disease with special emphasis on changing landscape of managing lipids, emergence of AI in cardiology imaging and understanding the different roles for outpatient noninvasive testing. The course will also focus on the emergence of cardiology in the management and treatment of peripheral arterial disease and atrial fibrillation. Advancements in the field that are continuously evolving with patient criteria will be presented including the move to PCI in an outpatient ASC setting, and Transcatheter therapies for Congestive Heart Failure as well as the role of Cardiac MR in the diagnosis and treatment for HCM and Heart Failure.

Saturday, February 22, 2025, 6:00 AM - 1:00 PM EST, Westin Hotel Richmond, Richmond, VA

1. Understand what’s new in lipid-lowering therapy including the role and efficacy of PCSK9 inhibitors
2. Discuss the role of Coronary CT Angiography (CTA) in primary prevention and the emerging role of Artificial Intelligence in CTA diagnostics and benefits to patients
3. Review the noninvasive testing options for the detection of Coronary Artery Disease and the prevention of cardiac events.
4. Understand Atrial Fibrillation treatment breakthroughs with Pulsed Field Ablation(PFA) and Left Atrial Appendage Occlusion vs Anticoagulation.
5. Identify the optimal strategy for screening for Peripheral Arterial Disease(PAD)
6. Understand and analyze therapeutic options for the management of PAD.
7. Increase knowledge in the identification and treatment of chronic venous insufficiency.
8. Discuss the future of Percutaneous Coronary Interventions in an outpatient setting.
9. Review the most recent recommendation for management of Heart Failure and the role of the care team
10. Discuss the evolving role of Cardiac MR and HCM in the management of Heart Failure.
11. Review the latest evidence in percutaneous Mitral Valve Clip therapy for Heart Failure.

AMA PRA Category 1 Credits™ (4.50 hours), ANCC Contact Hours (4.50 hours), Hours of Participation (4.50 hours)

All Provider Types: $50.00

Registration will close midnight on February 16, 2025. Space is Limited! 

NO WALK IN REGISTRATION.

Cancellation Policy

Cancellation requests received in writing no less than 30 days before the course will be refunded, less a 20% administrative fee. No refunds will be provided for cancellation requests received within 30 days or for registration fees of less than $50.  Please send cancellation requests [email protected].

 

UVA Health Continuing Education reserves the right to cancel CE activities if necessary.  In this case, the entire registration fee will be refunded.  All other expenses incurred in conjunction with this CE activity are the sole responsibility of the participant.

Accessibility Statement
 
UVACE is committed to ensuring equal access to educational opportunities for individuals with disabilities, in compliance with the Americans with Disabilities Act of 1990 (ADA), as amended, and Section 504 of the Rehabilitation Act of 1973 (Section 504), as well as other applicable state and local laws and University policy. Individuals with disabilities are entitled to reasonable accommodations to ensure their participation in courses. Please note that some of the course venues at UVA are registered historic properties and may not be fully ADA accessible. If you have needs that require special accommodation, including dietary concerns, please email [email protected].  All requests must be received 30 days prior to the course start date.

Mitigation of Relevant Financial Relationships

UVA Health Continuing Education adheres to the to the Joint Accreditation Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity.

To view financial disclosures, select the faculty name below.

Saturday, February 22, 2025

Please review:
Exhibitor Letter
Promotion and Exhibit Agreement.pdf
W-9

Exhibit at this Event